NCT04991428

Brief Summary

Intellectual impairment, particularly working memory deficits are a significant cause of morbidity in children with Neurofibromatosis type (NF1) with long-term implications on academic and occupational functioning. Whilst significant discoveries have been made in Nf1 animal models in trying to find treatments for these conditions, human translational studies have not been successful. This mechanistic experimental study will investigate the neural mechanisms underlying working memory deficits in NF1. In particular, we will investigate how individual differences in inhibitory neurotransmitter GABA relate to performance on working memory tests. Further, we will investigate the use of a novel, experimental intervention called transcranial Direct Current Stimulation (tDCS);known to modulate GABA. Using a randomized, crossover design in a cohort of 30 adolescents aged 11-17 years, we will apply real or sham tDCS to the dorsolateral prefrontal cortex (DLPFC). State-of-art real time imaging techniques such as Magnetic Resonance Spectroscopy (MRS) and task based functional MRI (fMRI) will be used to investigate the effect of tDCS on GABA concentration, changes in functional plasticity and working memory. We expect that results from this study will help elucidate the neural mechanisms underlying working memory deficits in people with NF1 and show biologic activity for a novel, low-cost intervention that can be used for cognitive remediation in NF1. This kind of focused mechanism trial method is a highly promising approach to understanding the complex neural system pathology in a multifactorial neurodevelopmental condition like NF1.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 22, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

July 27, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 5, 2021

Completed
Last Updated

August 5, 2021

Status Verified

July 1, 2021

Enrollment Period

12 months

First QC Date

July 27, 2021

Last Update Submit

July 27, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Corsi Block task

    memory span task

    immediately after the intervention

Study Arms (2)

Active trancranial direct current stimulation

EXPERIMENTAL

Active stimulation for 15 minutes

Other: Transcranial direct current stimulation

Sham stimulation

SHAM COMPARATOR

Similar set-up but no actual stimulation

Other: Transcranial direct current stimulation

Interventions

tDCS is a form of non-invasive brain stimulation. tDCS is an established research tool for non-invasive modulation of neuroplasticity. It uses low-intensity DC currents to modulate spontaneous neuronal network activity by altering the resting membrane potential. Anodal tDCS has been shown to increase cortical excitability, reduce regional levels of GABA enhance LTP and synaptic plasticity.

Active trancranial direct current stimulationSham stimulation

Eligibility Criteria

Age11 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Meets National Institute of Health NF1 diagnostic criteria
  • Children aged 11-17 years
  • Written informed consent/assent

You may not qualify if:

  • No history of intracranial pathology other than asymptomatic optic pathway glioma or other asymptomatic and untreated NF1-associated white matter lesion
  • No history of epilepsy or any major mental illness
  • No MRI contraindications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Manchester

Manchester, Greater Manchester, M13 9QQ, United Kingdom

Location

MeSH Terms

Conditions

Neurofibromatosis 1

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

NeurofibromatosesNeurofibromaNerve Sheath NeoplasmsNeoplasms, Nerve TissueNeoplasms by Histologic TypeNeoplasmsNeoplastic Syndromes, HereditaryNeurocutaneous SyndromesNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Single-blind cross over experimental trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Senior Lecturer

Study Record Dates

First Submitted

July 27, 2021

First Posted

August 5, 2021

Study Start

February 22, 2019

Primary Completion

February 19, 2020

Study Completion

February 19, 2020

Last Updated

August 5, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share

Collected data will be available to share after publication of study findings

Shared Documents
STUDY PROTOCOL
Time Frame
The data will be made available upon request.

Locations